Lichtsteiner Foundation

Lichtsteiner Foundation

The Lichtsteiner Foundation was established in Bern in 2009 by Stephan Lichtsteiner, a former professional footballer who captained the Swiss national side and played for Juventus and Arsenal. He runs the foundation as President alongside brother Marco Lichtsteiner, who serves as Vice President, and family member Natascha Lichtsteiner on the Foundation Board. The entity was created to translate the family's private wealth into a structured vehicle for backing health-focused startups, rather than operating as a traditional multi-generational single family office. The foundation targets early-stage companies across MedTech, Life Science, Mental Health, Public Health and Wellbeing, deploying capital in the form of direct equity investments. Its mandate spans Switzerland and broader European markets, with a posture that allows it to act as a first institutional investor where scientific validation exists but commercial proof is still forming. The portfolio is assembled through direct deal-making rather than fund commitments, reflecting a hands-on approach shaped by the founders' network in Swiss entrepreneurial and athletic circles. The foundation is a member of SECA, the Swiss Private Equity & Corporate Finance Association, signaling an intent to participate in the regulated private-market ecosystem. The foundation operates with a deliberately lean governance structure — the disclosed leadership consists exclusively of Stephan, Marco and Natascha Lichtsteiner. The vehicle does not publicly report assets under management or deployment totals. No additional offices or affiliated investment entities have been disclosed, pointing to a single-location, single-strategy operation. What distinguishes the Lichtsteiner Foundation from other health-focused family vehicles is its hybrid identity — it functions as an early-stage direct investor yet is formally constituted as a foundation rather than a family office or venture firm. The absence of external limited partners means the foundation can absorb longer scientific development timelines without the pressure of fund-life constraints. The foundation structure also implies a link to philanthropic intent, though the entity frames its activity as equity investing for impact rather than pure grant-making.